MedTrace Logo

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

NCT04996316 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 1141

Last updated 2026-02-13

No results posted yet for this study

Summary

This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Conditions

  • Breast Carcinoma

Interventions

OTHER

Electronic Health Record Review

Health record reviewed

OTHER

Interview

Participate in interview

OTHER

Media Intervention

Use MammoScreen

OTHER

Survey Administration

Complete survey

OTHER

Training and Education

Undergo training

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Oregon Health and Science University

    collaborator OTHER

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Karen Eden, Ph.D. · Department of Medical Informatics and Clinical Epidemiology, OHSU Knight Cancer Institute

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-07
Primary Completion
2025-04-30
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04996316 on ClinicalTrials.gov